VZ VERIZON COMMUNICATIONS INC Insider Trading

EVP & Chief HR Officer Samantha Hammock sold 73,069 shares of VZ for $3,495,036.41, reducing holdings by 81.8%

Samantha Hammock sold 73,069 shares at $47.83 on 2026-05-29, totaling $3,495,036.41 and reducing her VZ holdings from 89,290 shares to 16,221 shares. The transaction occurred when the stock was trading at $47.88 currently, -7.4% from the 52-week high of $51.68, following a 90-day decline of -6.5%. For a company with $34.4B in quarterly revenue, $5.0B in net income, and a P/E of 11.54, this large proportional reduction in holdings by a senior HR executive merits disclosure review for any related talent or organizational context.

Verizon Director Hans Erik Vestberg sold 225,000 shares for $11.2M, retaining 13,023 shares post-transaction

Hans Erik Vestberg, a Director at Verizon, executed 3 separate sales totaling 225,000 shares for $11,163,150.00 at $49.61 per share on 2026-02-24. This represents a -94.5% reduction in his holdings, leaving him with only 13,023 shares versus his pre-transaction position of 238,023 shares. The stock was trading within 1.3% of its 52-week high at transaction time, and has appreciated 24.3% over the prior 30 days, establishing a favorable price environment for exit. The near-complete liquidation of a Director's position warrants examination of whether this reflects estate or diversification planning versus strategic sentiment, though the magnitude of the sale—disposing of virtually all equity stake—marks a material change in executive exposure to the company.

EVP Malady Kyle (VZ Business CEO) sold 20,000 shares at $40.49 on 2025-01-28; stock now $39.47.

Malady Kyle, EVP and Group CEO-VZ Business, sold 20,000 shares on 2025-01-28 at $40.49, reducing his holdings by 43.8% to 25.7K shares. The sale occurred when VZ was trading near its 52-week range ($37.81–$45.21), and the stock has since declined 1.3% over 30 days. His same-ticker history at VZ shows mixed timing: prior sells on 2024-02-22 and 2024-02-15 produced 90-day returns of -2.5% and +0.4% respectively, with 1 of 2 prior sales well-timed at the 90-day horizon. His cross-ticker track record reflects a 50.00% well-timed rate across 3 prior sales. The timing context is modest—near but not at a 52-week peak—and prior outcomes at this ticker provide limited predictive clarity on insider intent or market direction.

VZ EVP Kyle Malady sold 20,000 shares at $40.54 on 2025-01-27, reducing holdings to 45.7K shares (-30.5%)

Kyle Malady, EVP and Group CEO-VZ Business, executed a discretionary open-market sale of 20,000 shares for $810.8K on 2025-01-27, reducing his position from 65.7K to 45.7K shares—a -30.5% reduction in holdings. The sale occurred at $40.54, while the stock currently trades at $40.28, indicating no material price movement since the transaction. Across Malady's prior three same-ticker sales at VZ, only 1 of 2 measurable outcomes showed negative 90-day returns (well-timed by the standard that stock declines after executive sales). His cross-ticker track record across all tickers shows a 50.00% well-timed rate for sells with an average 90-day return of -1.0%, neither pattern strong enough to signal acute market timing acumen. The company's annual revenue is declining (-2.1% year-over-year) and the stock is trading at 10.9% below its 52-week high, providing some context for a substantial reduction in insider equity exposure.